How Big Pharma can be prevented from indiscriminately raising the prices of its drugs
By Robert Graham – – Monday, September 16, 2019
This week, senators and representatives have returned to Washington, D.C., after a five-week recess.
Most congressional members used that time period to criss-cross their state or district, talking to their constituents and hearing directly from them about what needs to be done in Washington.
They no doubt heard about immigration concerns, the impact of the trade war and overall frustrations with a lack of action in Washington. And, as I know I have, I’m willing to bet that most of them heard about the skyrocketing cost of prescription drugs as well.